The $ 26^{th} $ Scientific Conference of the Society on NeuroImmune Pharmacology: College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, June 1-3, 2022
Abstract The $ 26^{th} $ Scientific Conference of the Society on NeuroImmune Pharmacology (SNIP) at the University of Tennessee Health Science Center in Memphis, Tennessee, June 1-3, 2022, is SNIP’s first full-fledged meeting in person since the onset of the coronavirus disease-19 pandemic. The three-day meeting encompasses a variety of activities that include a pre-conference session, many scientific sessions (eight symposia and two plenary lectures), two special talks, a poster session, oral talks, a mentoring session for early career investigators, a diversity and inclusion SNIP committee session, a business meeting, and an award session. A conference summary, detailed program agenda, accepted poster abstracts, and presentation abstracts are included in this brief report published in advance of the meeting..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
|---|---|
| Enthalten in: |
NeuroImmune Pharmacology and Therapeutics - 1(2022), 1 vom: 25. März, Seite 51-107 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kumar, Santosh [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© 2022 the author(s), published by De Gruyter, Berlin/Boston |
|---|
| doi: |
10.1515/nipt-2022-0004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2143089481 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2143089481 | ||
| 003 | DE-627 | ||
| 005 | 20231205151456.0 | ||
| 007 | tu | ||
| 008 | 230813s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1515/nipt-2022-0004 |2 doi | |
| 035 | |a (DE-627)OLC2143089481 | ||
| 035 | |a (DE-B1597)nipt-2022-0004-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Kumar, Santosh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The $ 26^{th} $ Scientific Conference of the Society on NeuroImmune Pharmacology: College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, June 1-3, 2022 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © 2022 the author(s), published by De Gruyter, Berlin/Boston | ||
| 520 | |a Abstract The $ 26^{th} $ Scientific Conference of the Society on NeuroImmune Pharmacology (SNIP) at the University of Tennessee Health Science Center in Memphis, Tennessee, June 1-3, 2022, is SNIP’s first full-fledged meeting in person since the onset of the coronavirus disease-19 pandemic. The three-day meeting encompasses a variety of activities that include a pre-conference session, many scientific sessions (eight symposia and two plenary lectures), two special talks, a poster session, oral talks, a mentoring session for early career investigators, a diversity and inclusion SNIP committee session, a business meeting, and an award session. A conference summary, detailed program agenda, accepted poster abstracts, and presentation abstracts are included in this brief report published in advance of the meeting. | ||
| 700 | 1 | |a Dash, Chandravanu |4 aut | |
| 700 | 1 | |a Pendyala, Gurudutt |4 aut | |
| 700 | 1 | |a Yelamanchili, Sowmya V. |4 aut | |
| 700 | 1 | |a Maggirwar, Sanjay B. |4 aut | |
| 700 | 1 | |a Bidlack, Jean M. |0 (orcid)0000-0002-4305-5111 |4 aut | |
| 700 | 1 | |a Chang, Sulie L. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NeuroImmune Pharmacology and Therapeutics |d De Gruyter, 2022 |g 1(2022), 1 vom: 25. März, Seite 51-107 |h Online-Ressource |w (DE-627)1787399524 |w (DE-600)3107864-3 |x 2750-6665 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2022 |g number:1 |g day:25 |g month:03 |g pages:51-107 |
| 856 | 4 | 1 | |u https://doi.org/10.1515/nipt-2022-0004 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2022 |e 1 |b 25 |c 03 |h 51-107 | ||